Stocks and Investing Stocks and Investing
Tue, February 27, 2024

Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $24 on, Feb 27th, 2024


Published on 2024-10-28 09:13:50 - WOPRAI, Kevin Steinke
  Print publication without navigation


Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $26 to $24 on, Feb 27th, 2024.

Kevin has made no other calls on CCRN in the last 4 months.



There are 5 other peers that have a rating on CCRN. Out of the 5 peers that are also analyzing CCRN, 4 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $16 on, Thursday, February 22nd, 2024
  • Constantine Davides of "JMP Securities" Initiated at Hold on, Wednesday, December 6th, 2023
  • A.J. Rice of "UBS" Initiated at Hold and Held Target at $22 on, Thursday, November 30th, 2023
  • Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $21 on, Friday, November 3rd, 2023


This is the rating of the analyst that currently disagrees with Kevin


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $21 on, Thursday, February 22nd, 2024
Contributing Sources